Imricor Medical Systems (ASX:IMR) said Semmelweis University's Heart and Vascular Center in Hungary performed its first atrial flutter ablations guided by real-time magnetic resonance imaging, through the company's NorthStar 3D mapping system, according to a Thursday filing with the Australian bourse.
The company aims for continued expansion and growth across Europe, including adding more sites to the VISABL-VT clinical trial, the filing said.
Imricor Medical Systems shares rose past 2% in morning trade Thursday.
Price (AUD): $1.66, Change: $+0.040, Percent Change: +2.47%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.